Deck 12: Coevolution of Innate and Adaptive Immunity

Full screen (f)
exit full mode
Question
_____ has/have tyrosine phosphatase activity that interrupts the signaling pathways required for the activation of NK cells.

A)SHP-1
B)MIC proteins
C)KIR ligands
D)phosphoantigens
E)lipid-transfer proteins.
Use Space or
up arrow
down arrow
to flip the card.
Question
of the following describe Vav1 except _____.

A)guanine-nucleotide exchange factor
B)regulated by SHP-1
C)active when phosphorylated
D)found on the surface of NK cells
E)mediates signaling that promotes NK cells' release of cytotoxic granules.
Question
Identify the mismatched pair:

A)CD94:NKG2A; ITIM
B)NKG2D; MIC proteins
C)SHP-1; Vav1
D)2B4; IgG
E)HLA-E; leader-sequence peptide.
Question
Identify which of the following would be sufficient to activate NK cells.

A)NKG2A and CD94
B)NKG2D and 2B4
C)KIR2DL1 and KIR3DL1
D)CD56 and LFA-1.
Question
Explain (A)how the ligand for CD94:NKG2A serves as an indicator of non-infectious or non-malignant states of potential target cells,and (B)the consequence if ligand expression is compromised on target cells.
Question
Identify which of the following is not a characteristic of CD94:NKG2A.

A)contains a C-type lectin domain
B)is an inhibitory NK-cell receptor
C)binds to carbohydrate ligands
D)is a disulfide-linked heterodimer
E)contains an immunoreceptor tyrosine-based inhibitory motif (ITIM).
Question
only single receptor that can activate NK cells without the need for a second activating receptor is _____.

A)NKG2D
B)CD56
C)2B4
D)CD94:NKG2A
E)CD16a.
Question
At birth,the size of the repertoire of γ:δ T-cell receptors is _____ its size at adolescence.

A)smaller than
B)larger than
C)about the same as.
Question
Which of the following statements regarding NK cells is false?

A)They express either inhibitory receptors or activating receptors,but not both.
B)Their inhibitory receptors are necessary to prevent killing of healthy cells.
C)They all express CD56.
D)Because NK cells express diverse combinations of receptors,no single NK cell expresses them all.
E)Some of their activating and inhibitory receptors use MHC class I ligands.
Question
Which of the following is false regarding HLA-G?

A)It is expressed as transmembrane or secreted forms.
B)It binds to LILRB1 inside endosomes of NK cells.
C)It stimulates the production of angiogenic factors by activating NK cells.
D)It is expressed exclusively by extravillous trophoblast cells.
E)It engages inhibitory receptors on uterine NK cells.
Question
In contrast to CD1d,CD1a,b,and c are not expressed by _____.

A)professional antigen-presenting cells
B)epithelial cells
C)developing thymocytes.
Question
Which of the following is not a ligand for α:β T cells?

A)peptide antigens
B)lipid antigen
C)sulfatides
D)heterocyclic organic molecules.
Question
Natural killer cells (NK cells)carry activating and inhibitory receptors on their surface.
A.What property of NK cells do these receptors activate or inhibit,respectively? Explain your answer.
B.How are NK cells thought to use these receptors to recognize and eliminate virus-infected cells?
C.Why are the actions of NK cells categorized as innate immunity,and what do we know of their specificity for MHC class I molecules?
D.Why do the NK cells of the recipient of an organ transplant sometimes attack the transplanted tissue?
Question
All of the following develop in the thymus except _____.

A)α:β T cells
B)γ:δT cells
C)NK cells
D)NKT cells
E)MAIT cells.
Question
Which of the following characterize MIC-A and MIC-B proteins? (Select all that apply.)

A)recognized by NKG2D receptors of NK cells and some CD8 T cells
B)activate the <strong>Which of the following characterize MIC-A and MIC-B proteins? (Select all that apply.)</strong> A)recognized by NKG2D receptors of NK cells and some CD8 T cells B)activate the   signaling pathway C)activate mast cells in the intestinal wall D)closely related to MHC class I heavy chains E)bind to MHC class I molecules and activate CD8 T cells. <div style=padding-top: 35px> signaling pathway
C)activate mast cells in the intestinal wall
D)closely related to MHC class I heavy chains
E)bind to MHC class I molecules and activate CD8 T cells.
Question
of the following are characteristic of NK cells except _____.

A)they express Toll-like receptors
B)they are tolerant of healthy cells
C)they circulate in a partly activated state
D)they all express the same selection of activating and inhibitory NK-cell receptors
E)they can be activated by FcγRIIIA (CD16a).
Question
In the context of NK-cell inhibitory and activating receptors and maternal arterial invasion,explain the cause of (A)pre-eclampsia and (B)obstructed labor.Base your response on a pregnancy involving a fetus who has inherited a C2 epitope from the father but whose mother is homozygous for C1.
Question
Which of the following describe the characteristics of CD94:NKG2A? (Select all that apply.)

A)It is an activating receptor of NK cells.
B)It is an inhibitory receptor of NK cells.
C)It binds to specific allotypes of HLA-A,-B,and -C heavy chains.
D)It binds to complexes of leader sequences of HLA-A,-B,and -C heavy chains bound to HLA-E.
E)It is a member of the killer-cell immunoglobulin-like receptor (KIR)family.
Question
Charlene Cook,a 38-year-old primigravida,is 35 weeks pregnant.Until recently she has had an uneventful pregnancy.Two weeks ago,her obstetrician noted lower-extremity edema,trace protein in her urine (10-20 mg/dl),and normal blood pressure (120/80 mmHg).At today's appointment her blood pressure is elevated at 160/100 mmHg,she has marked proteinuria (3+; 300 mg/dl),worsening of ankle swelling,facial and hand swelling,and she mentions sudden onset of headache and visual disturbance.Charlene is admitted immediately to hospital and is diagnosed with pre-eclampsia.Within hours she is induced and gives birth to a healthy baby girl.In the context of uterine NK-cell function,which of the following is inconsistent with the cause of Charlene's pre-eclampsia?
a.There is inadequate extravillous trophoblast invasion of the spiral arteries or the uterus.
b.She has maternal homozygosity for the KIR A haplotype.
c.Uterine NK cells fail to secrete adequate amount of cytokines and growth factors needed to promote angiogenesis and remodeling of the maternal arteries.
d.The baby's father and mother are homozygous for the C1 epitope.
e.Insufficient activating signals were delivered to uterine NK cells.
ANSWERS
Question
Vγ9:Vδ2 T cells differ from α:β T cells in that they _____.(Select all that apply.)

A)respond to phosphorylated metabolic intermediates (phosphoantigens)of isoprenoid biosynthesis pathways
B)bind to lipid antigens presented by CD1
C)do not carry out gene rearrangement
D)are not subject to positive and negative selection in the thymus
E)have limited diversity of V gene rearrangement.
Question
CD1a,CD1b,and CD1c _____.(Select all that apply.)

A)are highly polymorphic and bind to a variety of pathogen-specific lipids
B)are encoded within the MHC on chromosome 6
C)express antigen-binding sites distinct from classical MHC class I molecules
D)are associated with β2-microglobulin at the surface of antigen-presenting cells
E)can bind to lipids in the endoplasmic reticulum or in endocytic vesicles.
Question
Explain the path taken by CD1 molecules that eventually bind to pathogen-derived lipids inside endosomes of the MHC class II compartment.
Question
If,during development,none of the KIRs expressed by a NK cell are able to interact with self-MHC class I molecules,then the NK cell retains expression of _____.

A)LILRBI
B)KIR2DL1
C)KIR2DL2/3
D)KIR3DL1
E)CD94:NKG2A.
Question
_____ express a limited range of diversity in their antigen receptors yet can still bind to large groups of pathogens expressing common chemical entities.(Select all that apply.)

A)α:βT cells
B)γ:δT cells
C)NK cells
D)NKT cells
E)B-1 cells.
Question
_____ binds to MIC-A and MIC-B,which are synthesized in response to infection in gut epithelium.(Select all that apply.)

A)MHC class I
B)NKG2D
C)Vγ:Vδ1
D)fibroblast growth factor
E)CD1.
Question
All NK cells express _____.(Select all that apply.)

A)CD3
B)MIC
C)NKG2D
D)KIR2DL1
E)CD56.
Question
CD1d differs from CD1a,CD1b,and CD1c in that _____.(Select all that apply.)

A)CD1d does not present lipid antigens
B)CD1d is expressed in a variety of epithelial tissues
C)CD1d presents antigen to NK T cells
D)strong memory responses are generated by CD1d
E)CD1d has a restricted receptor repertoire.
Question
_____ is a molecule expressed on NK cells and Vγ:Vδ1 T cells.

A)CD3
B)MIC-A
C)NKG2D
D)CD94:NKG2A
E)killer-cell immunoglobulin-like receptor (KIR).
Question
Match between columns
CD45RA
expressed on ~20% of circulating γ:δ T cells
CD45RA
permits entry of γ:δ T cells into infected tissues
CD45RA
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD45RA
expressed on terminally differentiated γ:δ T cells
CD45RA
presents lipid antigens to γ:δ T cells
CCR5
expressed on ~20% of circulating γ:δ T cells
CCR5
permits entry of γ:δ T cells into infected tissues
CCR5
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CCR5
expressed on terminally differentiated γ:δ T cells
CCR5
presents lipid antigens to γ:δ T cells
CCR7
expressed on ~20% of circulating γ:δ T cells
CCR7
permits entry of γ:δ T cells into infected tissues
CCR7
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CCR7
expressed on terminally differentiated γ:δ T cells
CCR7
presents lipid antigens to γ:δ T cells
CD27
expressed on ~20% of circulating γ:δ T cells
CD27
permits entry of γ:δ T cells into infected tissues
CD27
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD27
expressed on terminally differentiated γ:δ T cells
CD27
presents lipid antigens to γ:δ T cells
CD1d
expressed on ~20% of circulating γ:δ T cells
CD1d
permits entry of γ:δ T cells into infected tissues
CD1d
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD1d
expressed on terminally differentiated γ:δ T cells
CD1d
presents lipid antigens to γ:δ T cells
Question
Match between columns
Vα24–Jα18:Vβ11
lipid antigens presented by CD1d
Vα24–Jα18:Vβ11
phosphoantigens presented by BTN3A1
Vα24–Jα18:Vβ11
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vα24–Jα18:Vβ11
ringed metabolites of riboflavin presented by MR1
Vγ4:Vδ5
lipid antigens presented by CD1d
Vγ4:Vδ5
phosphoantigens presented by BTN3A1
Vγ4:Vδ5
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vγ4:Vδ5
ringed metabolites of riboflavin presented by MR1
Vα7.2–Jα33:Vβ2, -13, or -22.
lipid antigens presented by CD1d
Vα7.2–Jα33:Vβ2, -13, or -22.
phosphoantigens presented by BTN3A1
Vα7.2–Jα33:Vβ2, -13, or -22.
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vα7.2–Jα33:Vβ2, -13, or -22.
ringed metabolites of riboflavin presented by MR1
Vγ9:Vδ2
lipid antigens presented by CD1d
Vγ9:Vδ2
phosphoantigens presented by BTN3A1
Vγ9:Vδ2
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vγ9:Vδ2
ringed metabolites of riboflavin presented by MR1
lipid antigens presented by CD1d
phosphoantigens presented by BTN3A1
phospholipid antigens presented by endothelial protein C receptor (EPCR)
ringed metabolites of riboflavin presented by MR1
Question
Match between columns
scaffold lipid
an example of a lipid-transfer molecule found in endosomes
scaffold lipid
CD1d
scaffold lipid
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
scaffold lipid
phosphoantigen
scaffold lipid
CD1e
scaffold lipid
NKT-cell development
scaffold lipid
IL-12
scaffold lipid
MR1
second signal for NKT-cell activation
an example of a lipid-transfer molecule found in endosomes
second signal for NKT-cell activation
CD1d
second signal for NKT-cell activation
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
second signal for NKT-cell activation
phosphoantigen
second signal for NKT-cell activation
CD1e
second signal for NKT-cell activation
NKT-cell development
second signal for NKT-cell activation
IL-12
second signal for NKT-cell activation
MR1
sulfatide
an example of a lipid-transfer molecule found in endosomes
sulfatide
CD1d
sulfatide
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
sulfatide
phosphoantigen
sulfatide
CD1e
sulfatide
NKT-cell development
sulfatide
IL-12
sulfatide
MR1
lipid-transfer protein
an example of a lipid-transfer molecule found in endosomes
lipid-transfer protein
CD1d
lipid-transfer protein
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
lipid-transfer protein
phosphoantigen
lipid-transfer protein
CD1e
lipid-transfer protein
NKT-cell development
lipid-transfer protein
IL-12
lipid-transfer protein
MR1
riboflavin
an example of a lipid-transfer molecule found in endosomes
riboflavin
CD1d
riboflavin
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
riboflavin
phosphoantigen
riboflavin
CD1e
riboflavin
NKT-cell development
riboflavin
IL-12
riboflavin
MR1
promyelocytic leukemia zinc finger protein (PLZF)
an example of a lipid-transfer molecule found in endosomes
promyelocytic leukemia zinc finger protein (PLZF)
CD1d
promyelocytic leukemia zinc finger protein (PLZF)
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
promyelocytic leukemia zinc finger protein (PLZF)
phosphoantigen
promyelocytic leukemia zinc finger protein (PLZF)
CD1e
promyelocytic leukemia zinc finger protein (PLZF)
NKT-cell development
promyelocytic leukemia zinc finger protein (PLZF)
IL-12
promyelocytic leukemia zinc finger protein (PLZF)
MR1
saposin
an example of a lipid-transfer molecule found in endosomes
saposin
CD1d
saposin
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
saposin
phosphoantigen
saposin
CD1e
saposin
NKT-cell development
saposin
IL-12
saposin
MR1
BTN3A
an example of a lipid-transfer molecule found in endosomes
BTN3A
CD1d
BTN3A
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
BTN3A
phosphoantigen
BTN3A
CD1e
BTN3A
NKT-cell development
BTN3A
IL-12
BTN3A
MR1
Question
Match between columns
CD94:NKG2A
HLA-A
CD94:NKG2A
HLA-C
CD94:NKG2A
HLA-E
CD94:NKG2A
MIC-A and MIC-B
CD94:NKG2A
FasL
CD94:NKG2A
phosphoantigen
CD94:NKG2A
glycolipid antigen
FAS
HLA-A
FAS
HLA-C
FAS
HLA-E
FAS
MIC-A and MIC-B
FAS
FasL
FAS
phosphoantigen
FAS
glycolipid antigen
Vγ:Vδ T-cell receptor
HLA-A
Vγ:Vδ T-cell receptor
HLA-C
Vγ:Vδ T-cell receptor
HLA-E
Vγ:Vδ T-cell receptor
MIC-A and MIC-B
Vγ:Vδ T-cell receptor
FasL
Vγ:Vδ T-cell receptor
phosphoantigen
Vγ:Vδ T-cell receptor
glycolipid antigen
NKG2D
HLA-A
NKG2D
HLA-C
NKG2D
HLA-E
NKG2D
MIC-A and MIC-B
NKG2D
FasL
NKG2D
phosphoantigen
NKG2D
glycolipid antigen
Vγ:Vδ2 T-cell receptor
HLA-A
Vγ:Vδ2 T-cell receptor
HLA-C
Vγ:Vδ2 T-cell receptor
HLA-E
Vγ:Vδ2 T-cell receptor
MIC-A and MIC-B
Vγ:Vδ2 T-cell receptor
FasL
Vγ:Vδ2 T-cell receptor
phosphoantigen
Vγ:Vδ2 T-cell receptor
glycolipid antigen
CD1
HLA-A
CD1
HLA-C
CD1
HLA-E
CD1
MIC-A and MIC-B
CD1
FasL
CD1
phosphoantigen
CD1
glycolipid antigen
HLA-A
HLA-C
HLA-E
MIC-A and MIC-B
FasL
phosphoantigen
glycolipid antigen
HLA-A
HLA-C
HLA-E
MIC-A and MIC-B
FasL
phosphoantigen
glycolipid antigen
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/32
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 12: Coevolution of Innate and Adaptive Immunity
1
_____ has/have tyrosine phosphatase activity that interrupts the signaling pathways required for the activation of NK cells.

A)SHP-1
B)MIC proteins
C)KIR ligands
D)phosphoantigens
E)lipid-transfer proteins.
A
2
of the following describe Vav1 except _____.

A)guanine-nucleotide exchange factor
B)regulated by SHP-1
C)active when phosphorylated
D)found on the surface of NK cells
E)mediates signaling that promotes NK cells' release of cytotoxic granules.
D
3
Identify the mismatched pair:

A)CD94:NKG2A; ITIM
B)NKG2D; MIC proteins
C)SHP-1; Vav1
D)2B4; IgG
E)HLA-E; leader-sequence peptide.
D
4
Identify which of the following would be sufficient to activate NK cells.

A)NKG2A and CD94
B)NKG2D and 2B4
C)KIR2DL1 and KIR3DL1
D)CD56 and LFA-1.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
5
Explain (A)how the ligand for CD94:NKG2A serves as an indicator of non-infectious or non-malignant states of potential target cells,and (B)the consequence if ligand expression is compromised on target cells.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
6
Identify which of the following is not a characteristic of CD94:NKG2A.

A)contains a C-type lectin domain
B)is an inhibitory NK-cell receptor
C)binds to carbohydrate ligands
D)is a disulfide-linked heterodimer
E)contains an immunoreceptor tyrosine-based inhibitory motif (ITIM).
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
7
only single receptor that can activate NK cells without the need for a second activating receptor is _____.

A)NKG2D
B)CD56
C)2B4
D)CD94:NKG2A
E)CD16a.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
8
At birth,the size of the repertoire of γ:δ T-cell receptors is _____ its size at adolescence.

A)smaller than
B)larger than
C)about the same as.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
9
Which of the following statements regarding NK cells is false?

A)They express either inhibitory receptors or activating receptors,but not both.
B)Their inhibitory receptors are necessary to prevent killing of healthy cells.
C)They all express CD56.
D)Because NK cells express diverse combinations of receptors,no single NK cell expresses them all.
E)Some of their activating and inhibitory receptors use MHC class I ligands.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
10
Which of the following is false regarding HLA-G?

A)It is expressed as transmembrane or secreted forms.
B)It binds to LILRB1 inside endosomes of NK cells.
C)It stimulates the production of angiogenic factors by activating NK cells.
D)It is expressed exclusively by extravillous trophoblast cells.
E)It engages inhibitory receptors on uterine NK cells.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
11
In contrast to CD1d,CD1a,b,and c are not expressed by _____.

A)professional antigen-presenting cells
B)epithelial cells
C)developing thymocytes.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
12
Which of the following is not a ligand for α:β T cells?

A)peptide antigens
B)lipid antigen
C)sulfatides
D)heterocyclic organic molecules.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
13
Natural killer cells (NK cells)carry activating and inhibitory receptors on their surface.
A.What property of NK cells do these receptors activate or inhibit,respectively? Explain your answer.
B.How are NK cells thought to use these receptors to recognize and eliminate virus-infected cells?
C.Why are the actions of NK cells categorized as innate immunity,and what do we know of their specificity for MHC class I molecules?
D.Why do the NK cells of the recipient of an organ transplant sometimes attack the transplanted tissue?
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
14
All of the following develop in the thymus except _____.

A)α:β T cells
B)γ:δT cells
C)NK cells
D)NKT cells
E)MAIT cells.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
15
Which of the following characterize MIC-A and MIC-B proteins? (Select all that apply.)

A)recognized by NKG2D receptors of NK cells and some CD8 T cells
B)activate the <strong>Which of the following characterize MIC-A and MIC-B proteins? (Select all that apply.)</strong> A)recognized by NKG2D receptors of NK cells and some CD8 T cells B)activate the   signaling pathway C)activate mast cells in the intestinal wall D)closely related to MHC class I heavy chains E)bind to MHC class I molecules and activate CD8 T cells. signaling pathway
C)activate mast cells in the intestinal wall
D)closely related to MHC class I heavy chains
E)bind to MHC class I molecules and activate CD8 T cells.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
16
of the following are characteristic of NK cells except _____.

A)they express Toll-like receptors
B)they are tolerant of healthy cells
C)they circulate in a partly activated state
D)they all express the same selection of activating and inhibitory NK-cell receptors
E)they can be activated by FcγRIIIA (CD16a).
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
17
In the context of NK-cell inhibitory and activating receptors and maternal arterial invasion,explain the cause of (A)pre-eclampsia and (B)obstructed labor.Base your response on a pregnancy involving a fetus who has inherited a C2 epitope from the father but whose mother is homozygous for C1.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
18
Which of the following describe the characteristics of CD94:NKG2A? (Select all that apply.)

A)It is an activating receptor of NK cells.
B)It is an inhibitory receptor of NK cells.
C)It binds to specific allotypes of HLA-A,-B,and -C heavy chains.
D)It binds to complexes of leader sequences of HLA-A,-B,and -C heavy chains bound to HLA-E.
E)It is a member of the killer-cell immunoglobulin-like receptor (KIR)family.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
19
Charlene Cook,a 38-year-old primigravida,is 35 weeks pregnant.Until recently she has had an uneventful pregnancy.Two weeks ago,her obstetrician noted lower-extremity edema,trace protein in her urine (10-20 mg/dl),and normal blood pressure (120/80 mmHg).At today's appointment her blood pressure is elevated at 160/100 mmHg,she has marked proteinuria (3+; 300 mg/dl),worsening of ankle swelling,facial and hand swelling,and she mentions sudden onset of headache and visual disturbance.Charlene is admitted immediately to hospital and is diagnosed with pre-eclampsia.Within hours she is induced and gives birth to a healthy baby girl.In the context of uterine NK-cell function,which of the following is inconsistent with the cause of Charlene's pre-eclampsia?
a.There is inadequate extravillous trophoblast invasion of the spiral arteries or the uterus.
b.She has maternal homozygosity for the KIR A haplotype.
c.Uterine NK cells fail to secrete adequate amount of cytokines and growth factors needed to promote angiogenesis and remodeling of the maternal arteries.
d.The baby's father and mother are homozygous for the C1 epitope.
e.Insufficient activating signals were delivered to uterine NK cells.
ANSWERS
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
20
Vγ9:Vδ2 T cells differ from α:β T cells in that they _____.(Select all that apply.)

A)respond to phosphorylated metabolic intermediates (phosphoantigens)of isoprenoid biosynthesis pathways
B)bind to lipid antigens presented by CD1
C)do not carry out gene rearrangement
D)are not subject to positive and negative selection in the thymus
E)have limited diversity of V gene rearrangement.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
21
CD1a,CD1b,and CD1c _____.(Select all that apply.)

A)are highly polymorphic and bind to a variety of pathogen-specific lipids
B)are encoded within the MHC on chromosome 6
C)express antigen-binding sites distinct from classical MHC class I molecules
D)are associated with β2-microglobulin at the surface of antigen-presenting cells
E)can bind to lipids in the endoplasmic reticulum or in endocytic vesicles.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
22
Explain the path taken by CD1 molecules that eventually bind to pathogen-derived lipids inside endosomes of the MHC class II compartment.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
23
If,during development,none of the KIRs expressed by a NK cell are able to interact with self-MHC class I molecules,then the NK cell retains expression of _____.

A)LILRBI
B)KIR2DL1
C)KIR2DL2/3
D)KIR3DL1
E)CD94:NKG2A.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
24
_____ express a limited range of diversity in their antigen receptors yet can still bind to large groups of pathogens expressing common chemical entities.(Select all that apply.)

A)α:βT cells
B)γ:δT cells
C)NK cells
D)NKT cells
E)B-1 cells.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
25
_____ binds to MIC-A and MIC-B,which are synthesized in response to infection in gut epithelium.(Select all that apply.)

A)MHC class I
B)NKG2D
C)Vγ:Vδ1
D)fibroblast growth factor
E)CD1.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
26
All NK cells express _____.(Select all that apply.)

A)CD3
B)MIC
C)NKG2D
D)KIR2DL1
E)CD56.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
27
CD1d differs from CD1a,CD1b,and CD1c in that _____.(Select all that apply.)

A)CD1d does not present lipid antigens
B)CD1d is expressed in a variety of epithelial tissues
C)CD1d presents antigen to NK T cells
D)strong memory responses are generated by CD1d
E)CD1d has a restricted receptor repertoire.
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
28
_____ is a molecule expressed on NK cells and Vγ:Vδ1 T cells.

A)CD3
B)MIC-A
C)NKG2D
D)CD94:NKG2A
E)killer-cell immunoglobulin-like receptor (KIR).
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
29
Match between columns
CD45RA
expressed on ~20% of circulating γ:δ T cells
CD45RA
permits entry of γ:δ T cells into infected tissues
CD45RA
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD45RA
expressed on terminally differentiated γ:δ T cells
CD45RA
presents lipid antigens to γ:δ T cells
CCR5
expressed on ~20% of circulating γ:δ T cells
CCR5
permits entry of γ:δ T cells into infected tissues
CCR5
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CCR5
expressed on terminally differentiated γ:δ T cells
CCR5
presents lipid antigens to γ:δ T cells
CCR7
expressed on ~20% of circulating γ:δ T cells
CCR7
permits entry of γ:δ T cells into infected tissues
CCR7
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CCR7
expressed on terminally differentiated γ:δ T cells
CCR7
presents lipid antigens to γ:δ T cells
CD27
expressed on ~20% of circulating γ:δ T cells
CD27
permits entry of γ:δ T cells into infected tissues
CD27
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD27
expressed on terminally differentiated γ:δ T cells
CD27
presents lipid antigens to γ:δ T cells
CD1d
expressed on ~20% of circulating γ:δ T cells
CD1d
permits entry of γ:δ T cells into infected tissues
CD1d
expressed on central memory γ:δ T cells but not effector memory γ:δ T cells
CD1d
expressed on terminally differentiated γ:δ T cells
CD1d
presents lipid antigens to γ:δ T cells
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
30
Match between columns
Vα24–Jα18:Vβ11
lipid antigens presented by CD1d
Vα24–Jα18:Vβ11
phosphoantigens presented by BTN3A1
Vα24–Jα18:Vβ11
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vα24–Jα18:Vβ11
ringed metabolites of riboflavin presented by MR1
Vγ4:Vδ5
lipid antigens presented by CD1d
Vγ4:Vδ5
phosphoantigens presented by BTN3A1
Vγ4:Vδ5
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vγ4:Vδ5
ringed metabolites of riboflavin presented by MR1
Vα7.2–Jα33:Vβ2, -13, or -22.
lipid antigens presented by CD1d
Vα7.2–Jα33:Vβ2, -13, or -22.
phosphoantigens presented by BTN3A1
Vα7.2–Jα33:Vβ2, -13, or -22.
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vα7.2–Jα33:Vβ2, -13, or -22.
ringed metabolites of riboflavin presented by MR1
Vγ9:Vδ2
lipid antigens presented by CD1d
Vγ9:Vδ2
phosphoantigens presented by BTN3A1
Vγ9:Vδ2
phospholipid antigens presented by endothelial protein C receptor (EPCR)
Vγ9:Vδ2
ringed metabolites of riboflavin presented by MR1
lipid antigens presented by CD1d
phosphoantigens presented by BTN3A1
phospholipid antigens presented by endothelial protein C receptor (EPCR)
ringed metabolites of riboflavin presented by MR1
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
31
Match between columns
scaffold lipid
an example of a lipid-transfer molecule found in endosomes
scaffold lipid
CD1d
scaffold lipid
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
scaffold lipid
phosphoantigen
scaffold lipid
CD1e
scaffold lipid
NKT-cell development
scaffold lipid
IL-12
scaffold lipid
MR1
second signal for NKT-cell activation
an example of a lipid-transfer molecule found in endosomes
second signal for NKT-cell activation
CD1d
second signal for NKT-cell activation
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
second signal for NKT-cell activation
phosphoantigen
second signal for NKT-cell activation
CD1e
second signal for NKT-cell activation
NKT-cell development
second signal for NKT-cell activation
IL-12
second signal for NKT-cell activation
MR1
sulfatide
an example of a lipid-transfer molecule found in endosomes
sulfatide
CD1d
sulfatide
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
sulfatide
phosphoantigen
sulfatide
CD1e
sulfatide
NKT-cell development
sulfatide
IL-12
sulfatide
MR1
lipid-transfer protein
an example of a lipid-transfer molecule found in endosomes
lipid-transfer protein
CD1d
lipid-transfer protein
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
lipid-transfer protein
phosphoantigen
lipid-transfer protein
CD1e
lipid-transfer protein
NKT-cell development
lipid-transfer protein
IL-12
lipid-transfer protein
MR1
riboflavin
an example of a lipid-transfer molecule found in endosomes
riboflavin
CD1d
riboflavin
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
riboflavin
phosphoantigen
riboflavin
CD1e
riboflavin
NKT-cell development
riboflavin
IL-12
riboflavin
MR1
promyelocytic leukemia zinc finger protein (PLZF)
an example of a lipid-transfer molecule found in endosomes
promyelocytic leukemia zinc finger protein (PLZF)
CD1d
promyelocytic leukemia zinc finger protein (PLZF)
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
promyelocytic leukemia zinc finger protein (PLZF)
phosphoantigen
promyelocytic leukemia zinc finger protein (PLZF)
CD1e
promyelocytic leukemia zinc finger protein (PLZF)
NKT-cell development
promyelocytic leukemia zinc finger protein (PLZF)
IL-12
promyelocytic leukemia zinc finger protein (PLZF)
MR1
saposin
an example of a lipid-transfer molecule found in endosomes
saposin
CD1d
saposin
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
saposin
phosphoantigen
saposin
CD1e
saposin
NKT-cell development
saposin
IL-12
saposin
MR1
BTN3A
an example of a lipid-transfer molecule found in endosomes
BTN3A
CD1d
BTN3A
fills up bottom of antigen-binding site to allow antigenic lipid to be accessible on the top
BTN3A
phosphoantigen
BTN3A
CD1e
BTN3A
NKT-cell development
BTN3A
IL-12
BTN3A
MR1
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
32
Match between columns
CD94:NKG2A
HLA-A
CD94:NKG2A
HLA-C
CD94:NKG2A
HLA-E
CD94:NKG2A
MIC-A and MIC-B
CD94:NKG2A
FasL
CD94:NKG2A
phosphoantigen
CD94:NKG2A
glycolipid antigen
FAS
HLA-A
FAS
HLA-C
FAS
HLA-E
FAS
MIC-A and MIC-B
FAS
FasL
FAS
phosphoantigen
FAS
glycolipid antigen
Vγ:Vδ T-cell receptor
HLA-A
Vγ:Vδ T-cell receptor
HLA-C
Vγ:Vδ T-cell receptor
HLA-E
Vγ:Vδ T-cell receptor
MIC-A and MIC-B
Vγ:Vδ T-cell receptor
FasL
Vγ:Vδ T-cell receptor
phosphoantigen
Vγ:Vδ T-cell receptor
glycolipid antigen
NKG2D
HLA-A
NKG2D
HLA-C
NKG2D
HLA-E
NKG2D
MIC-A and MIC-B
NKG2D
FasL
NKG2D
phosphoantigen
NKG2D
glycolipid antigen
Vγ:Vδ2 T-cell receptor
HLA-A
Vγ:Vδ2 T-cell receptor
HLA-C
Vγ:Vδ2 T-cell receptor
HLA-E
Vγ:Vδ2 T-cell receptor
MIC-A and MIC-B
Vγ:Vδ2 T-cell receptor
FasL
Vγ:Vδ2 T-cell receptor
phosphoantigen
Vγ:Vδ2 T-cell receptor
glycolipid antigen
CD1
HLA-A
CD1
HLA-C
CD1
HLA-E
CD1
MIC-A and MIC-B
CD1
FasL
CD1
phosphoantigen
CD1
glycolipid antigen
HLA-A
HLA-C
HLA-E
MIC-A and MIC-B
FasL
phosphoantigen
glycolipid antigen
HLA-A
HLA-C
HLA-E
MIC-A and MIC-B
FasL
phosphoantigen
glycolipid antigen
Unlock Deck
Unlock for access to all 32 flashcards in this deck.
Unlock Deck
k this deck
locked card icon
Unlock Deck
Unlock for access to all 32 flashcards in this deck.